Sixfold Bioscience logo — RNA delivery, evolved.

Sixfold Bioscience

RNA delivery, evolved.

Founded 2017 United Kingdom London, United Kingdom 18 employees Grant Total: $10.62M Biotechnology, Health and Wellness

General Information

Company Name Sixfold Bioscience
Founded Year 2017
Location United Kingdom London, United Kingdom
Employees 18
Industries Biotechnology, Health and Wellness
Funding Stage Grant

BounceWatch is an independent company data service, not affiliated with Sixfold Bioscience. To contact Sixfold Bioscience, visit sixfold.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Sixfold Bioscience

Sixfold Bioscience is a biotechnology startup headquartered in the United Kingdom. Founded in 2018, the company focuses on RNA delivery. Their recent achievement includes a significant $8.30M grant investment secured on 2nd December 2021. The investment came from notable backers including Innovate UK, MedCity News, and the European Commission.

With their slogan "RNA delivery, evolved," Sixfold Bioscience is positioning itself as a pioneer in the health and wellness sector. Their innovative approach to RNA delivery holds great potential for addressing critical medical needs and advancing biotechnological solutions. The recent injection of funds is expected to propel their research and development efforts, solidifying their stance in the competitive biotech landscape.

Taxonomy: RNA therapies, preclinical-stage biotech, innovative research, in vivo delivery systems, Y Combinator, venture capitalists, award-winning company, London-based biotech, Cambridge University, Francis Crick Institute

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $2.20M 5
Y Combinator, LombardStreet Ventures +3
02 Dec 2021
Grant $8.30M 3
Innovate UK, MedCity News +1
02 Dec 2021
Pre Seed Round Undisclosed 1
LombardStreet Ventures
14 Apr 2018
Pre Seed Round $120.00K 1
Pi Campus
04 Jan 2018

Sixfold Bioscience Alternatives & Competitors

View All Alternatives
Sixfold Bioscience vs

Unlocking liver regeneration - delivering recovery

15 employees
Biotechnology, Health Care
Sixfold Bioscience vs

Innovative pediatric immunotherapies for Real-life Possibilities

Post-IPO Equity
59 employees
Biotechnology, Health Care
Sixfold Bioscience vs
Visterra Inc.
Visterra Inc. United States

We bring better biologics to life. Biospace Best Place to Work 2024!

Series C
139 employees
Biotechnology, Health Care

FAQ About Sixfold Bioscience

RNA delivery, evolved.
Sixfold Bioscience was founded in 2017.
Sixfold Bioscience is headquartered in London, United Kingdom.
Sixfold Bioscience operates in Biotechnology and Health and Wellness. Its work centres on RNA therapies, preclinical-stage biotech, innovative research and in vivo delivery systems.
Sixfold Bioscience has approximately 18 employees.
Sixfold Bioscience has completed 4 funding rounds, raising a total of $10.62M. The latest funding stage is Grant.
Top alternatives and competitors to Sixfold Bioscience include HepaRegeniX GmbH, Y-mAbs Therapeutics, Inc., Visterra Inc., Hemostemix Inc., Starna Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sixfold Bioscience and HepaRegeniX GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sixfold Bioscience, https://bouncewatch.com/company/sixfold-bioscience, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes